Evidence map›Paper›PMID 32010304›Full record

ArticleExperimental and therapeutic medicine2020

Antioxidant, anti-inflammatory and anti-fibrotic effects of

Heba M Eltahir, Michael A Fawzy, Elhussein M Mohamed, Mahmoud A Alrehany, Ahmed M Shehata, Mekky M Abouzied

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04487964 (Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine), which is not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04487964 nacompletednot on this map

Evaluation of The Potential Therapeutic Effects of Licorice and Boswellia Serrata Gum in Egyptian Patients With COVID-19 as a Complementary Medicine

TypeinterventionalSponsorEgyptian Biomedical Research NetworkRan2020 to 2021Enrolled50ConditionsCOVID-19ArmsLicorice extract
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Effect of boswellia (Frontiers in clinical diabetes and healthcare · 2024
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Life (Basel, Switzerland) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. The journey of boswellic acids from synthesis to pharmacological activities.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  11. Article
  12. Article
  13. Amelioration of CClScientific reports · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Heba M EltahirDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina 11564, Kingdom of Saudi Arabia.
Michael A FawzyDepartment of Biochemistry, Faculty of Pharmacy, Minya University, Minya 61511, Egypt.
Elhussein M MohamedDepartment of Biochemistry, Faculty of Pharmacy, Minya University, Minya 61511, Egypt.
Mahmoud A AlrehanyDepartment of Biochemistry, Faculty of Pharmacy, Deraya University, Minya 61768, Egypt.
Ahmed M ShehataDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina 11564, Kingdom of Saudi Arabia.
Mekky M AbouziedDepartment of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Medina 11564, Kingdom of Saudi Arabia.
Taibah University · SAMinia University Hospital · EGDeraya University

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study aims to investigate the potential antioxidant, anti-inflammatory and anti-fibrotic effects of Boswellia serrate (BS) gum resin against carbon tetrachloride (CCl

Indexed as

boswellia serratacyclooxygenase-2hepatoprotectiveinterleukin-6liver fibrosistransforming growth factor-β

Identifiers

PMID32010304
PMCPMC6966228
OpenAlexW2994842761

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.